...
首页> 外文期刊>Pediatric emergency care >Pediatric ziprasidone overdose.
【24h】

Pediatric ziprasidone overdose.

机译:小儿齐拉西酮过量。

获取原文
获取原文并翻译 | 示例
           

摘要

We describe the first ziprasidone overdose with quantitative serum levels of a pediatric patient in coma and with pinpoint pupils. This case is an important contribution to the pediatric ziprasidone literature because it illustrates that ingestion of just 1 pill may result to profound mental status and respiratory depression in a child. H.C., a 30-month-old girl, presented to the emergency department approximately 30 minutes after an accidental ingestion of an adult family member's medication. The child was found on the floor surrounded by numerous pills and was witnessed to have ingested at least 1 tablet by a caregiver. After finding the child with the pills, the family observed the child for a brief period but transported her to the hospital after she became lethargic and unresponsive. The child received 2 doses of 0.4 mg of intravenous naloxone without change in her neurologic status. The child then underwent a rapid sequence intubation for airway protection and subsequently received gastrointestinal decontamination with 15 g of activated charcoal via the orogastric tube. Ziprasidone is an atypical antipsychotic drug that was approved by the Food and Drug Administration in February 2001 for the general treatment of schizophrenia in adults. Previously reported pediatric ziprasidone overdoses describe a syndrome of sedation, tachycardia, hypotonia, and coma consistent with that of the patient described in this paper. In pediatric ziprasidone overdose, QTc prolongation and hypotension have also been illustrated, but seizures have not been reported. An interesting aspect of this case is the development of pinpoint pupils unresponsive to naloxone. This phenomenon has been reported before with overdose of olanzapine, a similar atypical antipsychotic. The mechanism of miosis associated with overdose of atypical antipsychotics is unclear but is likely related to interference with central innervation of the pupil. Pupil size is maintained by a balance between sympathetic and parasympathetic neurohumeral tones. We propose that an overdose of an alpha-1 receptor blocking agent, such as ziprasidone, results in unopposed parasympathetic stimulation resulting in miosis.
机译:我们用定量的儿童昏迷小儿和精确的瞳孔描述了第一次西拉西酮过量。该病例是小儿齐拉西酮文献的重要贡献,因为它表明仅摄入1粒药可能会导致儿童精神状态严重和呼吸抑制。 30岁的女孩H.C.在意外摄入成年家庭成员的药物后约30分钟出现在急诊室。该儿童被发现在地板上,周围被许多药丸包围,并被护理人员目睹至少摄入了1片药片。在找到带有药丸的孩子后,一家人短暂地观察了这个孩子,但在她变得昏昏欲睡且反应迟钝后将其送往医院。这名儿童接受了2剂0.4毫克的静脉注射纳洛酮,神经系统状况没有改变。然后,对孩子进行快速顺序插管以保护气道,随后通过口胃管用15 g活性炭进行胃肠道净化。 Ziprasidone是一种非典型的抗精神病药物,2001年2月获得美国食品药品监督管理局(FDA)的批准,可用于成人精神分裂症的一般治疗。先前报道的小儿齐拉西酮过量描述了与本文所述患者相一致的镇静,心动过速,低渗和昏迷综合征。在小儿齐拉西酮过量中,QTc延长和低血压也已被证实,但癫痫发作尚未见报道。这种情况的一个有趣的方面是对纳洛酮无反应的精确小学生的发展。过量服用奥氮平(一种类似的非典型抗精神病药)之前,曾报道过这种现象。与过量的非典型抗精神病药有关的瞳孔缩小的机制尚不清楚,但可能与干扰瞳孔的中枢神经支配有关。通过交感神经和副交感神经肱音之间的平衡来维持瞳孔大小。我们建议,过量的α-1受体阻断剂(例如齐拉西酮)会导致无反感的副交感神经刺激,从而导致瞳孔缩小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号